<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03749954</url>
  </required_header>
  <id_info>
    <org_study_id>CHESS1801</org_study_id>
    <nct_id>NCT03749954</nct_id>
  </id_info>
  <brief_title>Magnetically Controlled Capsule Endoscopy for Assessing Risk of Gastroesophageal Varices Bleeding in Compensated Cirrhosis (CHESS1801)</brief_title>
  <official_title>Magnetically Controlled Capsule Endoscopy for Assessing Risk of Gastroesophageal Varices Bleeding in Compensated Liver Cirrhosis (CHESS1801): A Prospective Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanfang Hospital of Southern Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>PLA Army General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sir Run Run Shaw Hospital, Medical College, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zhujiang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shandong Provincial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Tongji Hospital, Tongji University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Nanchang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zhongda Hospital, Medical School, Southeast University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guangdong Second Provincial General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>the Fifth Affiliated Hospital of Zunyi Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>LanZhou University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xingtai People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nanfang Hospital of Southern Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gastroesophageal varices occurs in approximately half of the patients with cirrhosis.
      Variceal bleeding is the most common lethal complication directly from cirrhotic portal
      hypertension. The gold standard for diagnosing gastroesophageal varices and evaluating the
      risk of variceal bleeding is the esophagogastroduodenoscopy. According to the Baveno VI
      consensus, for those with high-risk varices (varies needing treatment), either non-selective
      beta blockers or endoscopic band ligation is recommended for the prevention of the first
      variceal bleeding. However, the invasiveness and uncomfortableness during the
      esophagogastroduodenoscopy procedure has hindered its use in clinical practice, especially in
      patients with compensated cirrhosis.

      Magnetically controlled capsule endoscopy, as an emerging non-invasive technique, has been
      well established and shown the comparable accuracy for detection of focal lesions in the
      stomach compared with conventional esophagogastroduodenoscopy. In the present study, the
      investigators aim to conduct a prospective, multicenter diagnostic trial with 12 sites in
      China to further evaluate the diagnostic performance of magnetically controlled capsule
      endoscopy (Ankon Medical Technologies Co. Ltd.) for assessing risk of gastroesophageal
      varices bleeding in compensated cirrhosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Gastroesophageal varices occurs in approximately half of the patients with cirrhosis.
      Variceal bleeding is the most common lethal complication directly from cirrhotic portal
      hypertension. The gold standard for diagnosing gastroesophageal varices and evaluating the
      risk of variceal bleeding is the esophagogastroduodenoscopy. According to the Baveno VI
      consensus, for those with high-risk varices (varies needing treatment), either non-selective
      beta blockers or endoscopic band ligation is recommended for the prevention of the first
      variceal bleeding. However, the invasiveness and uncomfortableness during the
      esophagogastroduodenoscopy procedure has hindered its use in clinical practice, especially in
      patients with compensated cirrhosis.

      Magnetically controlled capsule endoscopy, as an emerging non-invasive technique, has been
      well established and shown the comparable accuracy for detection of focal lesions in the
      stomach compared with conventional esophagogastroduodenoscopy. In the present study, the
      investigators aim to conduct a prospective, multicenter diagnostic trial with 12 sites (PLA
      Army General Hospital; Sir Run Run Shaw Hospital, Medical College, Zhejiang University;
      Zhujiang Hospital, Southern Medical University; Shandong Provincial Hospital affiliated to
      Shandong University; Shanghai Tongji Hospital, Tongji University School of Medicine; The
      First Affiliated Hospital of Nanchang University; Nanfang Hospital, Southern Medical
      University; Zhongda Hospital, Medical School, Southeast University; Guangdong Second
      Provincial General Hospital; The Fifth Affiliated Hospital of Zunyi Medical University; The
      First Hospital of Lanzhou University; Xingtai People's Hospital) in China to further evaluate
      the diagnostic performance of magnetically controlled capsule endoscopy (Ankon Medical
      Technologies Co. Ltd.) for assessing risk of gastroesophageal varices bleeding in compensated
      cirrhosis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 9, 2018</start_date>
  <completion_date type="Anticipated">November 8, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 8, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic accuracy of magnetically controlled capsule endoscopy for the risk of variceal bleeding</measure>
    <time_frame>1 day</time_frame>
    <description>Diagnostic accuracy of magnetically controlled capsule endoscopy to determine the high-risk or low-risk of variceal bleeding when compared with esophagogastroduodenoscopy as the reference standard</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diagnostic accuracy of magnetically controlled capsule endoscopy for decompensation or death</measure>
    <time_frame>3 year</time_frame>
    <description>Diagnostic accuracy of magnetically controlled capsule endoscopy to determine the presence or absence of decompensation (defined as development of ascites, bleeding, or overt encephalopathy) or death within 3-year follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diagnostic accuracy of other non-invasive methods for the risk of variceal bleeding</measure>
    <time_frame>1 day</time_frame>
    <description>Diagnostic accuracy of other non-invasive methods to determine the high-risk or low-risk of variceal bleeding when compared with esophagogastroduodenoscopy as the reference standard</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diagnostic accuracy of other non-invasive methods for decompensation or death</measure>
    <time_frame>3 year</time_frame>
    <description>Diagnostic accuracy of other non-invasive methods to determine the presence or absence of decompensation (defined as development of ascites, bleeding, or overt encephalopathy) or death within 3-year follow-up</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Compensated Cirrhosis</condition>
  <condition>Gastroesophageal Varices Bleeding</condition>
  <arm_group>
    <arm_group_label>Overall eligible participants</arm_group_label>
    <description>Eligible participants will receive standard esophagogastroduodenoscopy and magnetically controlled capsule endoscopy (Ankon Medical Technologies Co. Ltd.).</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Magnetically controlled capsule endoscopy</intervention_name>
    <description>Esophagogastroduodenoscopy is performed 2 hours after the magnetically controlled capsule endoscopy (Ankon Medical Technologies Co. Ltd.).</description>
    <arm_group_label>Overall eligible participants</arm_group_label>
    <other_name>Esophagogastroduodenoscopy</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants with compensated cirrhosis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18-75 years;

          -  confirmed cirrhosis based on liver biopsy or clinical findings;

          -  compensated cirrhosis;

          -  scheduled to undergo esophagogastroduodenoscopy;

          -  estimated survival time&gt; 24 months, and model for end-stage liver disease (MELD)
             score&lt; 19;

          -  with written informed consent.

        Exclusion Criteria:

          -  contradictions for capsule endoscopy;

          -  contradictions for standard magnetic resonance imaging examination such as the
             presence of surgical metallic devices;

          -  pregnancy or unknown pregnancy status.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiaolong Qi, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>LanZhou University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiaolong Qi, M.D.</last_name>
    <phone>+8618588602600</phone>
    <phone_ext>+8618588602600</phone_ext>
    <email>qixiaolong@vip.163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yanna Liu</last_name>
    <phone>+8615625076784</phone>
    <phone_ext>+8618588602600</phone_ext>
    <email>lauyenna@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>PLA Army General Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shuai Wang, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Shuai Wang, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Hospital of Lanzhou University</name>
      <address>
        <city>Lanzhou</city>
        <state>Gansu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xun Li, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Xun Li, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Guangdong Second Provincial General Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ming Xu, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Ming Xu, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nanfang Hospital, Southern Medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jinlin Hou, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Jinlin Hou, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zhujiang Hospital, Southern Medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hua Mao, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Hua Mao, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Fifth Affiliated Hospital of Zunyi Medical University</name>
      <address>
        <city>Zhuhai</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhaohui He, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Zhaohui He, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Xingtai People's Hospital</name>
      <address>
        <city>Xingtai</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dengxiang Liu, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Dengxiang Liu, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zhongda Hospital, Medical School, Southeast University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruihua Shi, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Ruihua Shi, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Nanchang University</name>
      <address>
        <city>Nanchang</city>
        <state>Jiangxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xuan Zhu, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Xuan Zhu, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shandong Provincial Hospital affiliated to Shandong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chunqing Zhang, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Chunqing Zhang, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanghai Tongji Hospital, Tongji University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Li Yang, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Li Yang, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sir Run Run Shaw Hospital</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Weilin Hu, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Weilin Hu, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Qi X, Berzigotti A, Cardenas A, Sarin SK. Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension. Lancet Gastroenterol Hepatol. 2018 Oct;3(10):708-719. doi: 10.1016/S2468-1253(18)30232-2. Review.</citation>
    <PMID>30215362</PMID>
  </reference>
  <reference>
    <citation>Liu F, Ning Z, Liu Y, Liu D, Tian J, Luo H, An W, Huang Y, Zou J, Liu C, Liu C, Wang L, Liu Z, Qi R, Zuo C, Zhang Q, Wang J, Zhao D, Duan Y, Peng B, Qi X, Zhang Y, Yang Y, Hou J, Dong J, Li Z, Ding H, Zhang Y, Qi X. Development and validation of a radiomics signature for clinically significant portal hypertension in cirrhosis (CHESS1701): a prospective multicenter study. EBioMedicine. 2018 Oct;36:151-158. doi: 10.1016/j.ebiom.2018.09.023. Epub 2018 Sep 27.</citation>
    <PMID>30268833</PMID>
  </reference>
  <reference>
    <citation>Qi X, Li Z, Huang J, Zhu Y, Liu H, Zhou F, Liu C, Xiao C, Dong J, Zhao Y, Xu M, Xing S, Xu W, Yang C. Virtual portal pressure gradient from anatomic CT angiography. Gut. 2015 Jun;64(6):1004-5. doi: 10.1136/gutjnl-2014-308543. Epub 2014 Nov 14.</citation>
    <PMID>25398771</PMID>
  </reference>
  <reference>
    <citation>Wang FS, Fan JG, Zhang Z, Gao B, Wang HY. The global burden of liver disease: the major impact of China. Hepatology. 2014 Dec;60(6):2099-108. doi: 10.1002/hep.27406. Epub 2014 Oct 29. Review.</citation>
    <PMID>25164003</PMID>
  </reference>
  <reference>
    <citation>Zou WB, Hou XH, Xin L, Liu J, Bo LM, Yu GY, Liao Z, Li ZS. Magnetic-controlled capsule endoscopy vs. gastroscopy for gastric diseases: a two-center self-controlled comparative trial. Endoscopy. 2015 Jun;47(6):525-8. doi: 10.1055/s-0034-1391123. Epub 2015 Jan 15.</citation>
    <PMID>25590177</PMID>
  </reference>
  <reference>
    <citation>Liao Z, Hou X, Lin-Hu EQ, Sheng JQ, Ge ZZ, Jiang B, Hou XH, Liu JY, Li Z, Huang QY, Zhao XJ, Li N, Gao YJ, Zhang Y, Zhou JQ, Wang XY, Liu J, Xie XP, Yang CM, Liu HL, Sun XT, Zou WB, Li ZS. Accuracy of Magnetically Controlled Capsule Endoscopy, Compared With Conventional Gastroscopy, in Detection of Gastric Diseases. Clin Gastroenterol Hepatol. 2016 Sep;14(9):1266-1273.e1. doi: 10.1016/j.cgh.2016.05.013. Epub 2016 May 20.</citation>
    <PMID>27211503</PMID>
  </reference>
  <reference>
    <citation>de Franchis R; Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015 Sep;63(3):743-52. doi: 10.1016/j.jhep.2015.05.022. Epub 2015 Jun 3.</citation>
    <PMID>26047908</PMID>
  </reference>
  <reference>
    <citation>Berzigotti A, Seijo S, Arena U, Abraldes JG, Vizzutti F, García-Pagán JC, Pinzani M, Bosch J. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology. 2013 Jan;144(1):102-111.e1. doi: 10.1053/j.gastro.2012.10.001. Epub 2012 Oct 8.</citation>
    <PMID>23058320</PMID>
  </reference>
  <reference>
    <citation>Bhardwaj A, Kedarisetty CK, Vashishtha C, Bhadoria AS, Jindal A, Kumar G, Choudhary A, Shasthry SM, Maiwall R, Kumar M, Bhatia V, Sarin SK. Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial. Gut. 2017 Oct;66(10):1838-1843. doi: 10.1136/gutjnl-2016-311735. Epub 2016 Jun 13.</citation>
    <PMID>27298379</PMID>
  </reference>
  <reference>
    <citation>Rey JF, Ogata H, Hosoe N, Ohtsuka K, Ogata N, Ikeda K, Aihara H, Pangtay I, Hibi T, Kudo SE, Tajiri H. Blinded nonrandomized comparative study of gastric examination with a magnetically guided capsule endoscope and standard videoendoscope. Gastrointest Endosc. 2012 Feb;75(2):373-81. doi: 10.1016/j.gie.2011.09.030. Epub 2011 Dec 9.</citation>
    <PMID>22154417</PMID>
  </reference>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>November 17, 2018</study_first_submitted>
  <study_first_submitted_qc>November 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 21, 2018</study_first_posted>
  <last_update_submitted>June 15, 2019</last_update_submitted>
  <last_update_submitted_qc>June 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>LanZhou University</investigator_affiliation>
    <investigator_full_name>Xiaolong Qi</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Magnetically controlled capsule endoscopy</keyword>
  <keyword>Gastroesophageal varices bleeding</keyword>
  <keyword>Varices needing treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Esophageal and Gastric Varices</mesh_term>
    <mesh_term>Varicose Veins</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Undecided</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

